Prosiectau (2906)
Cardiff University Schools involved in this Project
STRETCHED: STRategies to manage Emergency ambulance Telephone Callers with sustained High needs- an Evaluation using linked Data (01.04.2019 - 30.09.2021)
- Edwards, Adrian
Structural analysis of the mTOR kinase domain by X-ray crystallography (01.10.2009 - 30.04.2013)
- Lai, Francis
Structural and biological characterisation of novel phosphatidylethanolamine lipids generated by 12/15-lox in monocytes and macrophages (08.01.2007 - 28.02.2010)
- O'Donnell, Valerie
Structural and functional impact of side-chain modification of peptides recognised by CD8+ cells (01.10.2015 - 31.12.2016)
- Man, Stephen
Structural investigations into the outcomes of genetic studies (01.06.2018 - 31.12.2021)
- Menzies, Georgina
Structural mechanisms of gating at the selectivity filter of the cardiac ryanodine receptor channel (RyR2) and a potential gate-coupling element (01.10.2011 - 30.09.2014)
- Williams, Alan
Structural studies of human immune system proteins (01.09.2014 - 30.09.2016)
- Rizkallah, Pierre
Structural studies of MAGE epitopes in human immune system proteins (01.12.2012 - 31.01.2014)
- Rizkallah, Pierre
Structure- Activity relationships for novel engineered high-affinity T cell receptors (10.10.2006 - 09.10.2009)
- Sewell, Andrew
Structure-function of the human cardiac release channel interaction with immunophilin (01.05.2006 - 16.02.2010)
- Lai, Francis
Studentship (01.07.2017 - 30.06.2020)
- Paisey, Stephen
Studentship (01.10.2017 - 30.09.2022)
- Paisey, Stephen
Studentship (01.10.2018 - 30.09.2022)
- Hughes, Timothy
Studentship (01.10.2018 - 30.09.2022)
- Rosser, Anne
Studentship (01.10.2020 - 30.09.2023)
- Ruthardt, Martin
Studentship (01.12.2021 - 30.11.2022)
- Tonks, Alex
Studentship (02.01.2019 - 20.01.2023)
- Toleman, Mark
Studentship (02.01.2020 - 31.12.2022)
- O'Donnell, Valerie
Studentship (03.01.2018 - 30.01.2022)
- Shin, Eunju
Studentship (03.01.2018 - 31.12.2020)
- Carson-Stevens, Andrew
Studentship (28.03.2017 - 31.03.2021)
- Daniel, Rhian
Studentship PHD - Abdulsalam Muharrab B Alruwaili (01.07.2021 - 02.06.2024)
- Tonks, Alex
Studies involving the diagnosis and treatment of immunodeficiency patients in Wales (01.09.2013 - 31.08.2015)
- Piguet, Vincent
Studies of the pathogenesis and cough in idopathic pulmonary fibrosis (01.01.2013 - 31.12.2014)
- Tonks, Mandy
Studies on lipid signalling in inflammation (01.04.2005 - 15.06.2008)
- O'Donnell, Valerie
Study into the effects of gremlin-1 in patients undergoing peritoneal dialysis and pre-clinical models of peritoneal membrane injury (01.09.2016 - 31.03.2019)
- Fraser, Donald
Study of the getting a life intervention to provide a seamless progression from school, through college or training into employment (01.04.2009 - 01.04.2011)
- Beyer, Stephen
-
- Alvares, Caroline
Study of the selective inhibitor of nuclear export (SINE) selinexor (KTP-330) versus specified physicians choice in patients > 60 years old with relapsed/refractory acute myeloid leukaemia who are ineligible for intensive chemotherapy (04.06.2015 - 06.04.2017)
- Alvares, Caroline
Sunesis lI-1 data access (28.02.2015 - 31.10.2015)
- Ottmann, Oliver
Sunitinib in advanced urothelial cancer in combination with standard cisplatin/gemcitabine chemotherapy treatment (26.11.2008 - 28.02.2014)
Super-agonist peptides as cancer vaccines (01.10.2019 - 01.01.2024)
- Sewell, Andrew
Superbugs 2: Digital Dissemination (12.01.2021 - 31.12.2021)
- Tyrrell, Jonathan
Supervision of company development project (01.10.2011 - 31.08.2013)
- Amso, Nazar
Supervision of company development project (01.10.2013 - 30.09.2014)
- Amso, Nazar
Supervision of company development project (01.10.2014 - 30.09.2015)
- Amso, Nazar
Supervision of company development project 2 (01.07.2008 - 30.09.2011)
- Amso, Nazar
Supplement to bridge existing ACC into collaborative ACC biomarker study. (01.10.2011 - 30.06.2012)
- Dayan, Colin
Support for research specifically in the field of growth hormone deficiency (01.09.2001 - 15.06.2010)
Support for speciality registrars on the Public Health training programme (06.08.2019 - 31.07.2024)
- Hurt, Lisa
Support for the Wales Life Science Initiative by Central Biotechnology Services (01.01.2014 - 31.12.2014)
- Weeks, Ian
Supporting activity engagement in people with Huntington's Disease: A phase II evaluation (ENGAGE-HD) (01.01.2013 - 31.12.2017)
- Busse-Morris, Monica
Supporting employment of those disadvantaged in the labour market (SETTLE) (01.10.2004 - 30.09.2006)
- Beyer, Stephen
Supporting fathers in the antenatal period and early childhood years (01.10.2019 - 01.04.2023)
- Robling, Michael
Supporting people bereaved during COVID-19: A mixed methods study of bereaved people’s experiences and the bereavement services supporting them (14.08.2020 - 13.02.2022)
- Harrop, Emily
Supporting people bereaved through advanced illness: A systematic review of the evidence and development of a core outcome set for bereavement research in palliative care (01.02.2016 - 30.04.2018)
- Harrop, Emily
Supporting the development of NICE clinical guidelines on the diagnosis and management of colorectal and anal cancer (01.04.2009 - 01.10.2010)
- Hargest, Rachel
Support of the Welsh Wound Innovative Initiative (31.03.2011 - 30.03.2014)
- Harding, Keith
Surveillance and association between antimicrobial use and resistance in clinical escherichia coli isolates from tertiary care hospitals in Faisalabad (01.08.2021 - 30.04.2022)
- Toleman, Mark
SYBEL (01.01.2023 - 31.12.2024)
- Szomolay, Barbara
Syndromic epilepsy and learning disability: Characterisation of phenotype and detection of pathogenic genomic copy number variations (01.09.2009 - 31.10.2012)
- Kerr, Michael
Synergism of NAB novel polymyxin-derivatives NAB-739 and NAB-815 with a fixed concentration of selected partner antibiotics (20.02.2017 - 31.12.2019)
- Walsh, Timothy
Synthetic non-biological T-cell antigens f (01.02.2013 - 31.07.2015)
- Sewell, Andrew
Systematic characterisation of the HCMV pathogenicity domain spontaneously lost form commonly used passaged strains (01.12.2016 - 31.05.2021)
- Tomasec, Peter
Systematic review and meta analysis on drug treatments for posttraumatic stress disorder, acute stress disorder and grief (05.09.2011 - 30.11.2011)
- Bisson, Jonathan
Systematic review of physical abuse (01.01.2013 - 31.12.2013)
- Kemp, Alison
Systematic review of physical abuse (01.12.2004 - 31.12.2012)
- Kemp, Alison
Systems Immunity PhD Studentship fund (01.10.2019 - 30.09.2022)
- Jones, Simon
Systems Immunity Research (01.12.2021 - 30.11.2031)
- Jones, Simon
Systems Lipidomics tools and resources for biomedical research; LIPID MAPS (01.06.2024 - 31.05.2029)
- O'Donnell, Valerie
Systems Lipidomics tools and resources for biomedical research; LIPID MAPS. Cash contribution for 523970 (01.06.2024 - 31.05.2029)
- O'Donnell, Valerie
T1D-Plus: a clinical trial platform for combined beta cell preservation therapy (01.09.2022 - 31.08.2026)
- Dayan, Colin
T1D-Plus: An adaptive trial platform for the study of combination therapies in new-onset T1D (01.12.2023 - 30.11.2026)
- Dayan, Colin
T1D UK Clinical Trials consortium - mechanistic core (01.01.2015 - 05.12.2021)
- Wong, Susan
T1D UK Immunotherapy Consortium: Clinical Engagement and Training (CET) Core (01.05.2015 - 30.03.2020)
- Dayan, Colin
TACTICC study (01.06.2015 - 31.12.2016)
- Godkin, Andrew
Take home naloxone Intervention Multi centre Emergency setting feasibility trial (TIME) (01.03.2018 - 31.08.2020)
- Edwards, Adrian
- Taking imaging into the therapeutic domain: self-regulation of brain systems for mental disorders
(01.11.2013 - 31.10.2018)- Linden, David
Talking about HPV related cancer: Development and testing of scripted consultations (01.07.2014 - 30.06.2016)
- Adams, Richard
Talking Trials: Exploration of clinical trial perceptions amongst BAME communities (01.04.2020 - 31.03.2022)
- Svobodova, Martina
Talking Trials: Participatory approaches to creating community dialogue (01.10.2022 - 31.01.2024)
- Svobodova, Martina
TAP Centre (01.01.2020 - 31.12.2022)
- Knapper, Steven
TAPERS study Excess Treatment Costs (01.10.2018 - 31.01.2022)
- Hall, Jeremy
Targeted stabilisation of human cardiac ryanodine receptors as a therapeutic strategy for cardiac disease (01.10.2009 - 30.09.2014)
- George, Christopher
Targeted vaccines for infectious disease and cancer (01.04.2010 - 30.09.2010)
- Sewell, Andrew
Targeted vaccines for infectious disease and cancer (31.03.2010 - 30.09.2012)
- Sewell, Andrew
Targeting alpha-beta - crystalline (CRYAB): A novel strategy to impede triple-negative breast cancer development (01.07.2014 - 31.01.2016)
- Cai, Jun
Targeting CD8 using “blocking anti CD8 antibodies” as a strategy to disable autoreactive CD8+ T-cells in Type 1 diabetes (01.01.2023 - 29.02.2024)
- Pearson, James
Targeting CLL cell survival and proliferation with bioactive cell penetrating peptides (01.10.2010 - 30.04.2014)
- Brennan, Paul
Targeting complement to treat fatty liver disease (01.10.2022 - 30.09.2025)
- Zhou, You
Targeting ERK signalling to emeliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2 (01.11.2019 - 31.10.2025)
- Hall, Jeremy
Targeting glucose metabolism for the treatment of Birt Hogg Dube Syndrome (01.10.2009 - 30.09.2010)
- Tee, Andrew
Targeting islet-specific CD8 Tcells in Type 1 diabetes (01.06.2015 - 31.01.2019)
- Wong, Susan
Targeting neuroinflammation in mTORC1 driven brain tumours (01.10.2019 - 31.05.2023)
- Tee, Andrew
Targeting NF-xB activation and proliferation signals in CLL (01.11.2013 - 31.07.2018)
- Pepper, Christopher
- Targeting novel anti-complement drugs to the brain for therapy of
dementia. (01.10.2021 - 31.12.2026)- Zelek, Wioleta
Targeting Ref1/STAT3 to treat Tuberous Sclerosis (01.04.2018 - 09.02.2023)
- Tee, Andrew
Targeting the CD8 coreceptor as a novel strategy for the treatment of type 1 diabetes (01.01.2013 - 31.12.2013)
Targeting the early endosome as a therapeutic strategy in neurodegenerative diseases (01.01.2024 - 31.12.2026)
- Connor-Robson, Natalie
Targeting the pathological pathways to Parkinson's (02.05.2018 - 01.08.2021)
- Webber, Caleb
Targeting the terminal pathway in complement - driven disease (30.06.2018 - 30.09.2018)
- Morgan, Paul
Targeting the terminal pathway in complement-driven disease (01.10.2016 - 30.09.2018)
- Morgan, Paul
Targeting tissue macrophage generation during inflammation as a mechanism to modulate the resolution of inflammation (31.07.2012 - 30.07.2015)
- Taylor, Philip
Targets for treatment in AML: discovery and translation (20.09.2015 - 23.08.2019)
- Darley, Richard
Targets for treatment in AML: Discovery and translation (01.04.2010 - 19.09.2013)
- Darley, Richard
Targets for treatment in AML: Discovery and translation (20.09.2013 - 01.12.2015)
- Darley, Richard
Target temperature management after cardiac arrest (01.04.2011 - 31.12.2013)
- Hood, Kerenza
Target validation, indication selection/prioritisation, review of pre-clinical validation efforts and overall strategy (08.08.2016 - 18.09.2019)
- Morgan, Paul
Taster for clinicians (10.08.2015 - 04.10.2015)
- Robertson, Neil
T cell correlates of successful immunotherapy (01.10.2015 - 30.09.2018)
- Sewell, Andrew